[go: up one dir, main page]

NO20016427L - Blandinger og fremgangsmåter for behandling av diagnose av lungekreft - Google Patents

Blandinger og fremgangsmåter for behandling av diagnose av lungekreft

Info

Publication number
NO20016427L
NO20016427L NO20016427A NO20016427A NO20016427L NO 20016427 L NO20016427 L NO 20016427L NO 20016427 A NO20016427 A NO 20016427A NO 20016427 A NO20016427 A NO 20016427A NO 20016427 L NO20016427 L NO 20016427L
Authority
NO
Norway
Prior art keywords
diagnosis
compositions
treatment
methods
lung cancer
Prior art date
Application number
NO20016427A
Other languages
English (en)
Norwegian (no)
Other versions
NO20016427D0 (no
Inventor
Tongtong Wang
Chaitanya S Bangur
Michael J Lodes
Gary R Fanger
Thomas S Vedvick
Darrick Carter
Marc W Retter
Jane Mannison
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/476,300 external-priority patent/US20030125245A1/en
Priority claimed from US09/589,184 external-priority patent/US6686447B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of NO20016427D0 publication Critical patent/NO20016427D0/no
Publication of NO20016427L publication Critical patent/NO20016427L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20016427A 1999-06-30 2001-12-28 Blandinger og fremgangsmåter for behandling av diagnose av lungekreft NO20016427L (no)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US34649299A 1999-06-30 1999-06-30
US41935699A 1999-10-15 1999-10-15
US46686799A 1999-12-17 1999-12-17
US09/476,300 US20030125245A1 (en) 1999-06-30 1999-12-30 Compositions and methods for therapy and diagnosis of lung cancer
US09/519,642 US6933363B1 (en) 1999-06-30 2000-03-06 Compositions and methods for therapy and diagnosis of lung cancer
US53307700A 2000-03-22 2000-03-22
US54625900A 2000-04-10 2000-04-10
US56040600A 2000-04-27 2000-04-27
US09/589,184 US6686447B1 (en) 1999-06-30 2000-06-05 Compositions and methods for the therapy and diagnosis of lung cancer
PCT/US2000/018061 WO2001000828A2 (fr) 1999-06-30 2000-06-30 Compositions et techniques de therapie et de diagnostic du cancer du poumon

Publications (2)

Publication Number Publication Date
NO20016427D0 NO20016427D0 (no) 2001-12-28
NO20016427L true NO20016427L (no) 2002-02-25

Family

ID=27578819

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016427A NO20016427L (no) 1999-06-30 2001-12-28 Blandinger og fremgangsmåter for behandling av diagnose av lungekreft

Country Status (15)

Country Link
US (1) US6630574B1 (fr)
EP (1) EP1196565A2 (fr)
JP (1) JP2004500029A (fr)
CN (1) CN1367829A (fr)
AR (1) AR032743A1 (fr)
AU (1) AU769143B2 (fr)
BR (1) BR0012069A (fr)
CA (1) CA2380873A1 (fr)
CZ (1) CZ20014718A3 (fr)
HU (1) HUP0201757A3 (fr)
MX (1) MXPA02000192A (fr)
NO (1) NO20016427L (fr)
NZ (1) NZ516381A (fr)
PL (1) PL354093A1 (fr)
WO (1) WO2001000828A2 (fr)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060084082A1 (en) * 1997-03-07 2006-04-20 Human Genome Sciences, Inc. 186 human secreted proteins
US20030211510A1 (en) * 1999-06-30 2003-11-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20020172952A1 (en) * 1999-06-30 2002-11-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20030170255A1 (en) * 1999-06-30 2003-09-11 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
AU5887700A (en) * 1999-10-19 2001-04-30 Millennium Pharmaceuticals, Inc. Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
US6893818B1 (en) 1999-10-28 2005-05-17 Agensys, Inc. Gene upregulated in cancers of the prostate
US6902890B1 (en) 1999-11-04 2005-06-07 Diadexus, Inc. Method of diagnosing monitoring, staging, imaging and treating cancer
WO2001036644A2 (fr) * 1999-11-18 2001-05-25 Curagen Corporation Polypeptide du type cytokine regule par la proteine wnt et acides nucleiques codant ce polypeptide
US7005499B1 (en) 1999-11-18 2006-02-28 Genentech, Inc. Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
US20020038012A1 (en) * 2000-02-22 2002-03-28 Gregory Donoho Novel human regulatory protein and polynucleotides encoding the same
EP1259604A1 (fr) * 2000-02-25 2002-11-27 Oxford GlycoSciences (UK) Limited Proteine bcmp 84 associee au cancer du sein
JP2003532417A (ja) * 2000-05-12 2003-11-05 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング Ｆ−ｂｏｘ含有タンパク質
JP2004506413A (ja) * 2000-06-23 2004-03-04 ジェネンテック・インコーポレーテッド 血管形成に関与する疾患の診断と治療のための組成物と方法
AR031250A1 (es) * 2000-07-11 2003-09-17 Corixa Corp Composiciones y metodos para la terapia y el diagnostico del cancer de pulmon
AU2001287004A1 (en) * 2000-09-01 2002-03-13 Government Of The United States, As Represented By The Secretary Of The Department Of Health And Human Services Xage-1, a gene expressed in multiple cancers, and uses thereof
US20060063230A1 (en) 2000-12-27 2006-03-23 Roman Naworth Sulfatases and methods of use thereof
US20040121311A1 (en) 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in livestock
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US20030027135A1 (en) 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
EP1516049A4 (fr) * 2001-05-11 2006-01-11 Corixa Corp Compositions et methodes de traitement et de diagnostic du cancer du poumon
EP1270732A1 (fr) * 2001-06-21 2003-01-02 Schuler, Gerold Transfection de cellules eucaryotes avec des polynucléotides linéaires par électroporation
US8073627B2 (en) 2001-06-26 2011-12-06 Ibis Biosciences, Inc. System for indentification of pathogens
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
WO2003027231A2 (fr) * 2001-09-04 2003-04-03 Bristol-Myers Squibb Company Polynucleotide codant pour une nouvelle proteine d'adaptation, pmn29, contenant le domaine d'homologie avec la pleckstrine et le domaine riche en proline
WO2003046165A1 (fr) * 2001-11-26 2003-06-05 Bayer Healthcare Ag Régulation de la protéine humaine de type aldose réductase
EP1578399A4 (fr) 2002-12-06 2007-11-28 Isis Pharmaceuticals Inc Procedes d'identification rapide de pathogenes chez l'homme et les betes
US8046171B2 (en) 2003-04-18 2011-10-25 Ibis Biosciences, Inc. Methods and apparatus for genetic evaluation
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
JP4643450B2 (ja) 2003-08-08 2011-03-02 株式会社ペルセウスプロテオミクス 癌高発現遺伝子
US7087733B2 (en) * 2003-09-02 2006-08-08 Ken-Shwo Dai Human ARL-related gene variants associated with cancers
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8242254B2 (en) 2003-09-11 2012-08-14 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US7666592B2 (en) 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
US8119336B2 (en) 2004-03-03 2012-02-21 Ibis Biosciences, Inc. Compositions for use in identification of alphaviruses
US8940488B2 (en) 2004-03-31 2015-01-27 Hiroyuki Aburatani Cancer diagnosis and treatment of cancer using anti-robo 1 antibody
WO2005095981A1 (fr) 2004-03-31 2005-10-13 Perseus Proteomics Inc. Diagnostic du cancer et traitement utilisant l’anticorps anti-robo1
JP4810533B2 (ja) 2004-05-24 2011-11-09 アイビス バイオサイエンシズ インコーポレイティッド ディジタルスレショルド化による選択的イオン濾過作用を用いた質量分光測定法
US20050266411A1 (en) 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
WO2006135400A2 (fr) 2004-08-24 2006-12-21 Isis Pharmaceuticals, Inc. Procedes pour l'identification rapide d'organismes recombinants
CN101072582B (zh) * 2004-12-06 2012-06-27 赛生制药有限公司 作为癌症疫苗佐剂的α胸腺肽
US8182992B2 (en) 2005-03-03 2012-05-22 Ibis Biosciences, Inc. Compositions for use in identification of adventitious viruses
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
WO2007014045A2 (fr) 2005-07-21 2007-02-01 Isis Pharmaceuticals, Inc. Procede pour l'identification et la quantification rapide de variants d'acide nucleique
WO2007013480A2 (fr) * 2005-07-29 2007-02-01 Oncotherapy Science, Inc. Criblage et methode therapeutique anti-nsclc ciblant le complexe cda1-kntc2
WO2008143627A2 (fr) 2006-09-14 2008-11-27 Ibis Biosciences, Inc. Procédé d'amplification ciblée de génome entier pour l'identification d'agents pathogènes
JP5680304B2 (ja) 2007-02-23 2015-03-04 アイビス バイオサイエンシズ インコーポレイティッド 迅速な法医学的ｄｎａ分析法
JP5117765B2 (ja) 2007-05-28 2013-01-16 国立大学法人 東京大学 抗ｒｏｂｏ１抗体を含むｐｅｔ用腫瘍診断剤
WO2008151023A2 (fr) 2007-06-01 2008-12-11 Ibis Biosciences, Inc. Procédés et compositions pour l'amplification par déplacement multiple d'acides nucléiques
DK2186889T3 (en) 2007-08-20 2015-06-08 Oncotherapy Science Inc CDCA1 PEPTID AND PHARMACEUTICAL COMPOSITION, INCLUDING THIS
TWI526219B (zh) 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗
WO2010033625A1 (fr) 2008-09-16 2010-03-25 Ibis Biosciences, Inc. Systèmes de manipulation de microplaques et produits-programmes informatiques et procédés connexes
EP2349549B1 (fr) 2008-09-16 2012-07-18 Ibis Biosciences, Inc. Cartouches de mélange, postes de mélange et kits, et système associé
EP2347254A2 (fr) 2008-09-16 2011-07-27 Ibis Biosciences, Inc. Unités de traitement d'échantillons, systèmes et procédés associés
WO2010093943A1 (fr) 2009-02-12 2010-08-19 Ibis Biosciences, Inc. Ensembles sonde d'ionisation
WO2011008972A1 (fr) 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Systèmes pour l'identification d'un bioagent
WO2011008971A1 (fr) 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Appareil de levage et de montage
US9890408B2 (en) 2009-10-15 2018-02-13 Ibis Biosciences, Inc. Multiple displacement amplification
NL2007536C2 (en) 2011-10-05 2013-04-08 Academisch Ziekenhuis Leiden Lumc Adjuvant compound.
DK3473707T3 (da) * 2012-05-25 2025-03-17 Cellectis Fremgangsmåder til engineering af allogen og immunsuppressiv resistent t-celle til immunoterapi
CN103212077B (zh) * 2013-04-09 2015-09-23 梅林� Erbin抑制剂在制备抗肿瘤药物中的应用
BR112016015595A2 (pt) * 2014-01-05 2017-10-24 Biomirna Holdings Ltd métodos de determinação de câncer de pulmão
HRP20210698T1 (hr) 2015-12-22 2021-09-17 Immatics Biotechnologies Gmbh Peptidi i kombinacija peptida za uporabu u imunoterapiji protiv karcinoma dojke i drugih karcinoma
WO2022246204A2 (fr) * 2021-05-21 2022-11-24 Ionis Pharmaceuticals, Inc. Composés pour réduire l'expression de ptbp1

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0246709A1 (fr) * 1986-05-20 1987-11-25 Stichting Katholieke Universiteit ADN recombinant et ADN complémentaire, ARN messager, protéine, anticorps et méthode de détection de cellules tumorales
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
CA2248355A1 (fr) * 1996-03-15 1997-09-18 Sagami Chemical Research Center Proteine antigene de membrane humaine de la superfamille t4 et adn codant pour cette proteine
US5776683A (en) * 1996-07-11 1998-07-07 California Pacific Medical Center Methods for identifying genes amplified in cancer cells
WO1998031800A2 (fr) * 1997-01-21 1998-07-23 Human Genome Sciences, Inc. Proteines humaines
US6146877A (en) * 1997-03-21 2000-11-14 The Trustees Of Columbia University In The City Of New York Identification of the progression elevated gene-3 and uses thereof
CA2306777A1 (fr) 1997-10-22 1999-04-29 Helix Research Institute Procede destine au criblage des clones d'adn-c pleine longueur
ID27813A (id) 1998-01-28 2001-04-26 Corixa Corp Senyawa-senyawa untuk terapi dan diagnosa kanker paru-paru dan metoda untuk penggunaannya
US20020102604A1 (en) 1999-12-08 2002-08-01 Milne Edwards Jean-Baptiste Dumas Full-length human cDNAs encoding potentially secreted proteins
EP1121437B1 (fr) 1998-10-15 2008-02-20 Novartis Vaccines and Diagnostics, Inc. Genes regules dans les cellules du cancer du sein metastatique et du cancer du colon
AU1208100A (en) 1998-10-15 2000-05-01 Genetics Institute Inc. Secreted expressed sequence tags (sests)
CA2296792A1 (fr) 1999-02-26 2000-08-26 Genset S.A. Sequences marqueurs exprimees et proteines humaines codees
WO2000055375A1 (fr) 1999-03-17 2000-09-21 Alphagene, Inc. Proteines secretees et polynucleotides les codant

Also Published As

Publication number Publication date
WO2001000828A2 (fr) 2001-01-04
AU769143B2 (en) 2004-01-15
PL354093A1 (en) 2003-12-29
US6630574B1 (en) 2003-10-07
CA2380873A1 (fr) 2001-01-04
AR032743A1 (es) 2003-11-26
CN1367829A (zh) 2002-09-04
AU5902700A (en) 2001-01-31
NZ516381A (en) 2004-03-26
WO2001000828A3 (fr) 2001-08-02
NO20016427D0 (no) 2001-12-28
JP2004500029A (ja) 2004-01-08
CZ20014718A3 (cs) 2003-01-15
HUP0201757A2 (en) 2002-09-28
HUP0201757A3 (en) 2010-01-28
MXPA02000192A (es) 2004-08-12
EP1196565A2 (fr) 2002-04-17
BR0012069A (pt) 2002-08-27

Similar Documents

Publication Publication Date Title
NO20016427L (no) Blandinger og fremgangsmåter for behandling av diagnose av lungekreft
NO20014769D0 (no) Preparat for behandling og diagnose av bryst cancer og fremgangsmåter for anvendelse derav
NO20023402D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av prostatakreft
NO20003853D0 (no) Forbindelser for terapi og diagnose av lungekreft og metoder for deres anvendelse
NO20010196D0 (no) Sammensetninger og fremgangsmåter for terapi og diagnose av prostatakreft
NO20030714D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av HER-2/NEU-assosierte maligniteter
NO20013002D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av ovariekreft
PL366626A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
NO20022592L (no) Forbindelser og fremgangsmåter for behandling og diagnose av Chlamydia-infeksjoner
EP1571968A4 (fr) Compositions et methodes permettant de diagnostiquer et de traiter une tumeur
EP1589933A4 (fr) Compositions et methodes pour le diagnostic et le traitement d'une tumeur
EP1578996A4 (fr) Compositions et methodes pour diagnostiquer et traiter des tumeurs
EP1572091A4 (fr) Compositions et methodes de diagnostic et de traitement de tumeurs
EP1553912A4 (fr) Compositions et methodes pour le diagnostic et pour le traitement d'une tumeur
NO20024972L (no) Blandinger og fremgangsmater for terapi og diagnose av brystkreft
EP1575571A4 (fr) Compositions et methodes de diagnostic et de traitement d'une tumeur
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
NO994932D0 (no) Blandinger og fremgangsmaater for behandling og diagnose av brystkreft
AU2002246519A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer
EP1446013A4 (fr) Compositions et methodes de traitement et de diagnostic du cancer des poumons
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
NO20014804D0 (no) Forbindelser for immunterapi og diagnose av brystkreft og fremgangsmåter for deres anvendelse
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
NO20025594L (no) Blandinger og fremgangsmåter for terapi og diagnose av brystkreft
EP1496743A4 (fr) Compositions et procedes destines au traitement et au diagnostic du cancer du poumon

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application